Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08037 CH BIOTECH SER
RT Nominal up1.070 +0.020 (+1.905%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Investment Properties0--0000
Property, plant, equip. & others248,50813.298%219,341100,53596,07394,710
Land & other Lease Assets16,5903.713%15,99623,68032,78210,784
Intangible Assets139,2380.288%138,838164,825177,396201,493
Interests in Asso. & JCEs0--0016,2200
Other Non-current Assets98,2626.017%92,685112,156263,263122,021

502,5987.655%466,860401,196585,734429,008
Current Assets
2025/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Inventories2,550-35.784%3,9719,27418,7254,738
Trade Receivables7,98813.579%7,03319,764751,89992,130
Cash & Bank Balances11,290-40.306%18,91372,08792,770150,554
Other Current Assets14,000-57.803%33,178160,04121,36330,352
Assets Held for Sale0--0000

35,828-43.216%63,095261,166884,757277,774
Current Liabilities
2025/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Trade Payables8,09810.132%7,3535,787206,44116,149
S-T Debt & Leases143,570-0.578%144,40494,66916,62163,614
Other Current Liabilities44,0237.749%40,85759,011325,602147,632
Liab asso w/ Assets Held for Sale0--0000

195,6911.597%192,614159,467548,664227,395
Net Current Assets(159,863)23.428%(129,519)101,699336,09350,379
Total Assets Less Current Liabilities342,7351.599%337,341502,895921,827479,387
Non-current Liabilities
2025/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
L-T Debt & Leases69,86360.871%43,4285,72765,1633,556
Other Non-current Liabilities60,98618.362%51,5256,44230,1449,936

130,84937.804%94,95312,16995,30713,492
Capital and Reserves
2025/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
  Share Capital97,5730.000%97,57396,32396,32396,323
  Reserves141,358-15.541%167,369366,431506,352299,075
  Others0--0000
Shareholders' Funds238,931-9.818%264,942462,754602,675395,398
Non-controlling Interests(27,045)19.912%(22,554)27,972223,84570,497
Others0--0000

211,886-12.584%242,388490,726826,520465,895
Commitments and Contingent Liabilities
2025/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Commitments----122,636208,374238,733400
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 11/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K$)HKD -32,006
%Change-59.951%
EPS / (LPS)HKD -0.033
NBV Per Share ($)HKD 0.245
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.